Search hospitals > California > Bakersfield
Comprehensive Blood and Cancer Center
Claim this profileBakersfield, California 93309
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Multiple Myeloma
Conducts research for Plasma Cell Neoplasms
98 reported clinical trials
2 medical researchers
Summary
Comprehensive Blood and Cancer Center is a medical facility located in Bakersfield, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Multiple Myeloma, Plasma Cell Neoplasms and other specialties. Comprehensive Blood and Cancer Center is involved with conducting 98 clinical trials across 62 conditions. There are 2 research doctors associated with this hospital, such as Ravindranath Patel and David Kanamori, MD.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
PD-L1 positive
Stage III
2Lung Cancer
Global LeaderStage IV
PD-L1 positive
EGFR
Top PIs
Ravindranath PatelComprehensive Blood and Cancer Center3 years of reported clinical research
Studies Breast Cancer
Studies Multiple Myeloma
6 reported clinical trials
15 drugs studied
David Kanamori, MDCBCC Global Research, Inc. at Comprehensive Blood and Cancer Center5 years of reported clinical research
Studies Lung Cancer
Studies Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Clinical Trials running at Comprehensive Blood and Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Cancer
Melanoma
Lymphoma
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
ARV-471
for Breast Cancer
This trial tests a new oral medicine, ARV-471, against an existing injectable treatment, fulvestrant, in people with advanced breast cancer that has spread. Both medicines aim to slow cancer growth by targeting estrogen receptors. ARV-471 is developed as an oral alternative to fulvestrant.
Recruiting2 awards Phase 35 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Comprehensive Blood and Cancer Center?
Comprehensive Blood and Cancer Center is a medical facility located in Bakersfield, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Multiple Myeloma, Plasma Cell Neoplasms and other specialties. Comprehensive Blood and Cancer Center is involved with conducting 98 clinical trials across 62 conditions. There are 2 research doctors associated with this hospital, such as Ravindranath Patel and David Kanamori, MD.